Clinical Trial: A multicenter, randomized, double-blind, positive-controlled, dose-climbing, phase II clinical trial was conducted to evaluate the safety, pharmacokinetic (PK) and pharmacodynamic (PD) characteristics of QP-6211 transversus abdis plane block for injection for postoperative analgesia in patients undergoing abdominal surgery (China)

China, Sept. 29 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A multicenter, randomized, double-blind, positive-controlled, dose-climbing, phase II clinical trial was conducted to evaluate the safety, pharmacokinetic (PK) and pharmacodynamic (PD) characteristics of QP-6211 transversus abdis plane block for injection for postoperative analgesia in patients undergoing abdominal surgery'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600133515

Registration Time: 2026/09/28

Type: Interventional study

Primary Sponsor: The Third Xiangya Hospital Central South University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=345...